LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results

Related

• 

  Complications or Are They: Why We Can NEVER Get Enough ReST

  Jeffrey S. Heier, MD

  Peter K. Kaiser, MD FASRS

  Geoffrey G. Emerson, MD, PhD, FASRS

  J. Michael Jumper, MD, FASRS

  Ehab N. ELRAYES, MD, PhD ,FASRS

  Daniel Simhaee, MD

  ASSAF DOTAN, MD

  Paul Hahn, MD, PhD, FASRS

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Earliest Diabetic Retinopathy Detection Using Optical Coherence Tomography Angiography (OCTA) Perfused Capillary Density

  Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO

  Annual Meeting Talks

  2018

• 

  Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial

  Rishi P. Singh, MD

  Annual Meeting Talks

  2018